NCT02592161

Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis

A Randomized, Single Center, Double Blind, Parallel, Placebo-controlled Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 166 (actual)
• Sponsor: Korea Health Industry Development Institute · Other Government
• Sex: Female
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

A randomized, single center, double blind, parallel, placebo-controlled, clinical study of efficacy and safety of Chung A Won and placebo for 24 weeks three times a day on the improvement of osteoporosis and symptoms in Women's older than 50 patients with osteoporosis.

Conditions

• Osteoporosis

Interventions

Type	Name	Description
DRUG	Experimental	Test drug : Granules, Chung A Won 3g (Eucommiaceae, Psoralea corylifolia, Walnut, Ginger) Three times a day, oral administration for 24weeks Reference drug : Granules, Placebo 3g (Lactose hydrate, Corn starch, Caramel pigment) Three times a day, oral administration for 24weeks

Timeline

• Start date: 2012-04-01
• Primary completion: 2013-11-01
• Completion: 2013-11-01
• First posted: 2015-10-30
• Last updated: 2015-10-30